HOE-402 (4 -amlno-2 -[4,4 -dimethyl-2 -oxo-1 -imldazolldinyl] -pyrimldlne-5 -A' -[trifluoromethylphenyl] -carboxamide-monohydrochloride) has been shown to exhibit hypolipidemic action in heterozygous Watanabe heritable hyperlipidemic rabbits. In all animals, elevated cholesterol levels were reduced to normal (from 3.0 to 1.5 mmol/L) after 3 weeks of HOE-402 treatment This was due entirely to reduction of low density lipoprotein (LDL) cholesterol and was paralleled by accelerated removal of plasma '"I-LDL. This reduction of LDL levels was not found in homozygous LDL receptor-defective animals, emphasizing the necessity of a functional LDL receptor system for the hypolipidemic action. The effect of HOE-402 on LDL receptor activity in the cultured hepatoma cell line HepG2 was also determined. When cells were incubated with plasma from treated animals (containing cholesterol 1.5 mmol/L and HOE-402 80 ng/mL), high-affinity cell-surface binding sites for LDL were induced more than threefold, as shown by Scatchard analysis of cell-surface binding data. Induction of the LDL receptor was detectable after 6 hours and was 300% after 18 hours. This induction was specific for LDL, as '"I-transferrin and ["Feltransferrin were internalized normally in HOE-402-treated cells. The increase of LDL receptor protein was related to induced LDL receptor mRNA levels (400%), as shown by quantification of Northern blotting experiments. These findings suggest that HOE-402 mediated its hypolipidemic action mainly via the LDL receptor pathway. It enhanced mRNA levels for LDL receptor, hence increasing its synthesis, which subsequently resulted in reduced plasma LDL levels. Apart from having pharmacological implications, this compound could be very useful in elucidating the components that regulate the gene expression of the LDL receptor. through a concerted regulation of two pathways J. A-that supply them with exogenous and endogenous cholesterol. When cells need cholesterol, they start the buildup of low density lipoprotein receptor (LDLr) protein to enhance the uptake of exogenous cholesterol. In addition, they increase the amount of enzymes responsible for de novo cholesterol synthesis. The balance of these pathways is particularly delicate, as it controls not only the intracellular level of cholesterol but also the extracellular blood cholesterol level. As a therapeutic method of keeping blood cholesterol levels down, this balance can be shifted toward enhanced uptake of cholesterol into the cells. By blocking de novo synthesis of cholesterol with certain drugs, cells rely on exogenous uptake and mediate this demand by increasing the synthesis of mRNA coding for the LDLr protein. 13 Besides blocking intracellular de novo synthesis, treatment with ethinyl estradiol also leads to dramatically enhanced LDLr activity. The enhanced LDL uptake from plasma into the liver leads to reduced plasma cholesterol levels. In both systems, the series of events that are triggered follow the most powerful pathway to reduce plasma cholesterol: synthesis of large amounts of mRNA for LDLr leads to a proportional increase in cellular receptor numbers. This rise in LDLr protein enhances the removal of LDL cholesterol (LDL-C) from the plasma, which results in the reduction of blood cholesterol levels. LDLr production operates within a variety of regulatory influences. The feedback regulation of LDLr synthesis via cholesterol and the influences of hormones are well accepted but are supplemented by new reports 14 describing additional effects. In this study we investigated whether the induction of the LDLr pathway could be triggered by administration of HOE-402 (4-amino-2-[4,4-dimethyl-2-oxo-l-imidazolidinyl]-pyrimidine-5-/v'-[trifluoromethylphenyl]-carboxamide-monohydrochloride). This substance has been shown in preliminary experiments by Granzer 5 to possess hypolipidemic action in rats. Although detailed information is still lacking, we found no effect by HOE-402 on 3-hydroxy-3-methylglutaryl coenzyme A reductase in HepG2 cells (E. Granzer and M. Leinweber, unpublished observation), and in addition, no structural similarity to any known inhibitor of HMG CoA reductase was seen. For this first intensive investigation of the cellular mechanism of the action of HOE-402, we used an animal model for decreased but inducible LDLr activity, the heterozygous Watanabe heritable hyperlipidemic (WHHL) rabbit, to show that the cellular effect of the substance is not overcome by regulatory influences in the intact organism. We followed plasma lipid parameters and measured 125 Iby guest on
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Methods

Analytical Methods and Chemicals
Total cholesterol, triglycerides, apoprotein B (apoB), and LDL-C were determined using commercially available reagent kits (Boehringer Mannheim, Mannheim, FRG). Protein content of lipoproteins and cells was determined by the method of Lowry et al. 6 Chemicals were obtained from Sigma Inc, and HOE-402 was supplied by Hoechst AG, Frankfurt, FRG.
Rabbits
Male New Zealand White rabbits (3.0 to 3.5 kg) were obtained from Madoerin, Switzerland. WHHL rabbits were raised in Vienna from a breeding pair obtained from J.L. Goldstein, University of Texas Southwestern Medical Center at Dallas. HOE-402 was administered orally each morning in a 1-mL emulsion of liquefied corn starch and carrot juice.
Preparation of Lipoproteins and Serum
Human LDL (d, 1.019 to 1.050 g/mL) was prepared as described. 7 Lipoprotein-deficient serum (LPDS) was prepared by ultracentrifugation according to the method of Goldstein et al 7 with the thrombin treatment omitted. Control serum was collected from the animals in the pretreatment period, and conditioned serum was taken in week 4 of the treatment. It was prepared by centrifugation to remove the clots, followed by heat inactivation of the complement system and sterilization through a 0.45-^m filter. Serum was then pooled and stored at -30°C.
Cells
HepG2 cells were obtained from American Type Culture Collection and grown in Eagle's minimum essential medium (MEM) (PAA, Linz, Austria) supplemented as stated in the legends to the figures. Three days before an experiment, cells were split into 5-cm dishes (NUNC, Roskilde, Denmark) and grown to 60% confluence in standard MEM. Additions of supplemented media were made as stated, from 18 to 2 hours before the uptake of LDL was determined.
Iodination of Lipoproteins and Assay of Internalization and Surface Binding
In each preparation, 2 mg LDL at 10 mg/mL was iodinated by the monochloride method to a specific activity of 300 cpm/ng. 8 For the in vivo determination of LDL turnover, 40xl0 6 cpm labeled LDL was injected into the marginal ear vein, and the disappearance of radioactivity was determined as described. 8 4 cpm/nmol). Internalization was assessed as the radioactivity found in cells after receptor-dependent input and degradation and output of radioactivity had reached equilibrium. For determination of uptake of labeled LDL, HepG2 cells were pregrown under conditions described and were assayed for internalization capacity or surface binding of labeled LDL according to Goldstein et al. 7 Values given are for specific uptake, which was calculated from the difference of total uptake minus uptake measured when a 40-fold excess of unlabeled LDL was present in the incubation medium of duplicate or triplicate incubations.
Quantification of mRNA by Northern Blotting
For RNA preparations a procedure described by Chomczynski and Sacchi 10 was used with slight modifications. Cells pretreated as described were washed and then lysed with 2 mL of heated solution I (5 mol/L guanidinium isothiocyanate and 10 mmol EDTA in 50 mmol tris[hydroxymethyl]aminomethane [Tris]-HCl; pH 7.5) and 160 ^12-mercaptoethanol. Total RNA (5 to 20 n%) was mixed with 2 volumes of FF-3-(N-morpholino)propanesulfonic acid (MOPS) (8% formaldehyde and 65% formamide in 350 mmol/L MOPS; pH 7) and separated on a 1% horizontal agarose gel containing 2 mmol/L EDTA, 5 mmol/L iodoacetamide, and 100 ng/mL ethidium bromide in 40 mmol/L MOPS (pH 7.0). RNA was then transferred to a Hybond N membrane (Amersham) by using 20 x saline-sodium citrate (SSC) (3 mol/L NaCl and 0.3 mol/L sodium citrate; pH 7). An LDLr cDNA probe (1) and a human /3-actin probe (kindly donated by D.W. Russell) were labeled by using a random-primer kit to a specific activity of 5x10 cpm/jig (Amersham). This labeled /3-actin probe was diluted sevenfold with unlabeled cDNA to give comparable intensities on exposure. After overnight prehybridization in a Hybaid hybridization oven (Biometra) at 42°C in 3x saline-sodium phosphate-EDTA buffer (50% formamide, 250 yuglmh denatured herring sperm DNA, and 0.1% bovine serum albumin; pH 7), hybridization of both probes was done overnight in the same buffer. Filters were then washed with 2x SSC and l x SSC containing 0.1% sodium dodecyl sulfate (SDS) at 42°C; 0.5 x SSC and 0.1 x SSC washes at 52°C; and a final wash with O.lx SSC containing 0.1% SDS at 60°C. The dried filters were exposed to a Cronex4 film (not preflashed; Du Pont) and quantified by densitometry.
Results
In Vivo Effect in the Intact Animal
We administered HOE-402 to a group of nine heterozygous WHHL rabbits. In alternating 3-and 4-day intervals, blood was drawn and assayed for total choles- terol ( Fig 1A) , LDL-C (Fig IB) , total plasma triglycerides ( Fig 1C) , and high density lipoprotein cholesterol (HDL-C) ( Fig ID) . Lipid parameters are shown for the three periods: days 1 to 8, pretreatment period; days 9 to 36, treatment with 10 mg/kg HOE-402; and days 37 to 64, without treatment to determine the washout. Food intake and animal weight were not significantly different from a group of animals that received only corn starch and carrot juice and that were housed in the same room. After 3 weeks of treatment a significant reduction in total cholesterol and LDL-C could be seen.
The reduced values persisted for a further 3 weeks after treatment was stopped. Total cholesterol fell from an average of 3.0 mmol/L in the pretreatment period to less than 1.5 mmol/L by the end of the treatment period. This reduction was almost entirely due to a reduction of LDL-C from 1.4 mmol/L to 0.3 mmol/L (day 36, after 27 days of treatment). Changes in apoB paralleled the trends seen with cholesterol values (data not shown).
Assuming that one apoB occupies one LDL particle, such findings agree with the assumption that LDL particles were reduced in number but not in their cholesterol content. No significant changes could be found in either the HDL fraction or total plasma triglycerides. As triglyceride values, which give a rough estimate of very low density lipoprotein (VLDL), the precursor of LDL, were not reduced during treatment, we considered reduced synthesis of VLDL and the consequent reduced input of LDL precursors to be of minor importance in the reduction of LDL. To obtain more direct evidence of whether enhanced LDL removal governed the observed LDL-C reduction, we performed a plasma clearance test with radiolabeled LDL. Two pairs of heterozygous animals were given liquefied corn starch and carrot juice with and without 10 mg HOE-402/kg of animal weight for 3 weeks, respectively. A plasma disappearance curve was then calculated as described 8 (Fig 2) . The half-life of LDL in untreated heterozygous animals (approximately 14 hours) was more than twice that of treated animals (6 hours). The mean plasma LDL level in the untreated animals (3.6 mmol/L) was 2.8-fold higher than in treated animals (1.3 mmol/L). From these values it appears that the synthetic rate of LDL was unaltered, and thus, the enhanced removal may be attributed to increased production of functional LDLr's from the wild-type allele as a consequence of the treatment. Alternatively, a reduced synthesis of LDL could have induced the equilibrium we noted at the end of the treatment. Such a situation would also result in enhanced tracer clearance. To evaluate the involvement of mechanisms not primarily dependent on the LDLr, we treated homozygous WHHL rabbits with HOE-402. These animals have almost entirely lost functional LDLr's due to a single gene defect. As a result, they have elevated production rates of LDL.
11 Both conditions lead to markedly elevated plasma LDL levels. The mean total plasma cholesterol levels were estimated in a pretreatment period and calculated for the high-cholesterol group (n=3) to be 15.3±4.7 and 10.2±1.7 mmol/L for the low-cholesterol group (n=2). The substance was given for 28 days; the total plasma cholesterol levels are shown in Fig 3. The differences between mean cholesterol values in the third and fourth weeks of treatment and the mean values of the control period were not statistically significant (P>.02).
Influence of HOE-402 on the Internalization of LDL in HepG2 Cells
From the results in the intact animal we reasoned that HOE-402 was taken up via intestinal absorption and transported to the liver, where it induced LDL removal. To gain direct evidence of an effect on hepatocytes, we used a human hepatocyte-derived cell line (HepG2) and incubated it in heat-inactivated serum collected from the rabbits in the pretreatment period (control serum) and at the end of the treatment period (conditioned serum). By using serum from treated animals we avoided the problems of solubility and biological availability of this extremely hydrophobic substance. The concentration of HOE-402 in conditioned serum was 80 ng/mL (0.2 ^mol/L). Incubation of HepG2 cells for 18 hours with MEM including from 1% to 50% of conditioned serum resulted in a proportional increase in LDL internalization (Fig 4) . From 20% to 50% of this increase of 125 I-LDL internalization reached approximately 400% of the value measured in cells grown in control serum. Control serum in concentrations of 10%, 25%, and 50% showed no changes in uptake. The time course of induction was measured in 25% conditioned serum and was found to occur very rapidly. The induction was detectable within 3 to 6 hours of incubation and reached a maximal value after 18 hours (Table) . So far, we could not rule out that association of HOE-402 with LDL might have altered the affinity of LDL to its receptor. To investigate changes of affinity induced by such association, saturation kinetics of cell-surface binding sites for LDL at 4°C were determined. The binding of 
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Effect of HOE-402 on Internalization of Iron and Transfer r in
The enhanced uptake of radiolabeled LDL may be attributed to a general stimulation of cell-surface receptors or, theoretically at least, to acceleration of the endocytotic machinery. 12 To clarify this, we investigated transferrin uptake into HepG2 cells under conditions that stimulated LDL uptake. An accelerated turnover of the endocytotic machinery could be detected by comparing the steady-state level of 125 undergoing retroendocytosis with the amount of iron delivered during several rounds of retroendocytosis under stimulation by HOE-402. Under these conditions transferrin was endocytosed via the transferrin receptor (370 fmol/mg cell protein, steady-state level), and iron collected in the endocytotic compartment (9120 fmol/mg per hour). Fig 6 shows 
I-labeled transferrin
nmol/L ^Fejtransferrin). After incubation for 1 hour (transferrin) and 3 hours (LDL), dishes were washed five times and cells lysed with sodium hydroxide for determination of radioactivity in a gamma counter (LKB mini-Gamma) and protein concentration. Values are the average of duplicate incubations from one experiment out of two identical independent experiments.
Regulation of LDLr mRNA in HepG2
Cells by Quantitative Northern blotting was used to determine LDLr mRNA levels in cells incubated with HOE-402 to see whether receptor induction starts directly at the transcription level. Fig 7 shows the results of one representative Northern blotting experiment out of three replicates. Determination of the level of actin mRNA compensated for individual recoveries of total mRNA in the preparation procedure. Using these actin signals as internal standards, the mRNA of LDLr was very low in cells grown on lipoprotein-rich fetal bovine serum (FBS) (Fig 7, first two lanes and bar designated  FBS-) . This ratio was markedly shifted when cells were grown for 16 hours in the same medium with 10~7 mol/L HOE-402 added (next two lanes; bar FBS + ). Here, although there was sufficient cholesterol in the medium to repress LDLr synthesis, LDLr mRNA production was derepressed significantly, resulting in a twofold enhancement. The ratio was even more elevated (fivefold) when FBS was saturated by incubation for 24 hours at room temperature with HOE-402 (bar FBS*+). Under conditions of cholesterol starvation, stimulation of LDLr mRNA was well above the values observed at cholesterol saturation (lanes and bar designated LPDS-). The induction stimulus by HOE-402 (lanes LPDS+) was able to increase LDLr activity above the already stimulated level found in cholesteroldeprived cells.
Discussion
In this study we report our investigations concerning the mechanism of HOE-402, a plasma cholesterol-re- ducing agent. This substance was shown both in vivo and in vitro to invoke a powerful reaction sequence of the LDLr pathway, as proposed by Goldstein and Brown, 13 leading from LDLr mRNA induction to reduced plasma cholesterol levels. In the animal model for defective but inducible LDLr's, the heterozygous WHHL rabbit, we observed an HOE-402-mediated reduction of plasma cholesterol of over 50%. Reduction in total plasma was exclusively due to reduction of LDL-C and mediated by enhanced clearance of LDL by the liver. A reduction of 1.5 mmol/L of total plasma cholesterol, from an average of 3 mmol/L to 1.5 mmol/L, paralleled a reduction from 1.4 to 0.2 mmol/L in the LDL fraction. The concomitant reduction of apoB provides strong evidence that LDL particles were reduced in number rather than in size or cholesterol content. Testing the plasma removal capacity showed that in treated heterozygous animals, the halflife of injected labeled LDL became shorter compared with untreated heterozygous animals, even shorter than in receptor-normal New Zealand White rabbits. Alto-gether we observed a more-than-twofold acceleration of catabolism with a comparable reduction in pool size. As the synthetic rate of LDL at equilibrium is equal to the catabolic rate (pool size x removal rate), our data suggest that LDL synthesis was not affected by the treatment. All reactions triggered by HOE-402 in heterozygous animals, thereby leading to LDL reduction, are also likely to occur in homozygous animals. 2 But if receptor activity itself were the underlying principle of the cholesterol-lowering action, then the enhanced production of LDLr protein in homozygous WHHL rabbits would not result in enhanced activity, as they produce receptor molecules that are functionally defective. Our finding that no plasma LDL reduction took place in such a system emphasizes the role of LDLr-mediated endocytosis.
Results from experiments with intact animals prompted us to test the effect of HOE-402 on isolated cells in tissue culture. A direct influence of HOE-402 should be detected independent of any regulatory mechanism occurring in the liver cells of intact animals. HepG2 cells have been repeatedly shown to exhibit receptor-mediated uptake of LDL sensitive to regulation. 314 These cells were incubated in serum prepared from treated animals and, as a control, with serum from the same animals collected in the pretreatment period. After removal of HOE-402-containing medium by thorough washing, internalization capacity was determined with labeled LDL. In these experiments we found detectable stimulation of LDLr-mediated endocytosis 3 to 6 hours after treatment with HOE-402 serum, which was maximal after 18 hours in a dosedependent manner. Increasing the concentration of serum from 1% to 50% also raised the supply of cholesterol, which normally leads to suppression of LDL endocytosis. However, we observed no suppression, indicating that HOE-402 can overcome downregulation of receptor activity. Scatchard analysis of the binding to cell-surface receptors at 4°C showed that the numbers of high-affinity binding sites were enhanced. A more than threefold increase in the number of binding sites was found, which offered an explanation for the elevated capacity of internalization. There was no influence on the affinity of the binding sites. Taken together, these findings extend our understanding of the mechanism underlying the reduction of plasma LDL-C mediated by HOE-402: plasma transports the active form of HOE-402 to cells, where it leads to an induction of the LDLr system. As the liver is the dominating organ in cholesterol removal, an extracellular to intrahepatic shift of LDL-C occurs. There is now general agreement that induction of LDLr mRNA accounts for an increase in LDLr protein that leads to enhanced plasma LDL uptake. One well-documented example for such a sequence in animals is the administration of pharmacological doses of estradiol. In rabbits this leads to a dose-dependent reduction of plasma LDL-C. 4 It has not been determined whether this treatment leads to a specific or composite regulation of mRNA or whether it triggers metabolic events before these that result in LDLr stimulation. Here we show that HOE-402 did not influence endocytosis of transferrin and iron, whereas in the same cells LDLr was induced by 250%. This emphasizes a specific action: as transferrin uptake is also an indicator of a cell's growth status, this suggests that the metabolic status of the cells was not otherwise affected.
In addition, we observed stimulation by HOE-402 under conditions that suppress LDLr activity. When the cholesterol supply to cells was enhanced by elevating serum concentration in the medium by severalfold, we observed derepressed mRNA levels of LDLr. So far, we have used in vivo prepared conditioned serum in our experiments. To rule out that a plasma factor induced by HOE-402 was the active agent of receptor stimulation, we also dissolved HOE-402 directly in serum and tested for mRNA induction. The enhancement of LDLr mRNA was likewise found when HOE-402 was directly, without intestinal resorption, added to the tissue-culture medium.
Considered together, the current data support the concept that a dramatic stimulation by HOE-402 of the LDLr activity mediates the rapid clearance of LDL in intact animals as well as cultured cells. One reasonable assumption for the mechanism was the enhancement of mRNA synthesis, which leads to an increased production of LDLr protein. The details of this enhancement are unclear. Our findings can be interpreted within the framework of the hypothesis that the compound itself or a complex with an intracellular protein controls LDLr gene expression. It is difficult, at this stage, to postulate a single and direct effect responsible for the hypolipidemic action of HOE-402. Although the rapid response of cells to the addition of HOE-402 suggests a direct regulation of LDLr mRNA, it cannot be ruled out that changes in the regulatory cell cholesterol pool occur first. We have not detected any sign that would suggest a change in the intracellular cholesterol pool. The molecular target of LDLr gene regulation by intracellular cholesterol has been investigated in detail. 15 ' 16 The molecules that couple LDLr gene expression to metabolic signals are under intensive investigation or are still unknown. 17 Our investigation might serve as an additional tool to achieve that task.
